Cargando…
Genetic characterization drives personalized therapy for early-stage non-small-cell lung cancer (NSCLC) patients and survivors with metachronous second primary tumor (MST): A case report
RATIONALE: The pathogenesis and progression of lung cancer is a complicated process in which many genes take part. But molecular gene testing is typically only performed in advanced-stage non-squamous non-small-cell lung cancer (NSCLC). The value of tyrosine kinase inhibitors (TKI) administration is...
Autores principales: | Ding, Xingchen, Wang, Linlin, Liu, Xijun, Sun, Xindong, Yu, Jinming, Meng, Xue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348162/ https://www.ncbi.nlm.nih.gov/pubmed/28272214 http://dx.doi.org/10.1097/MD.0000000000006221 |
Ejemplares similares
-
Metachronous double primary cancer of epithelial and mesenchymal origins: A case report of a rare clinical phenomenon
por: Wu, Hongzeng, et al.
Publicado: (2017) -
A nomogram for predicting survival of nasopharyngeal carcinoma patients with metachronous metastasis
por: Zeng, Zixun, et al.
Publicado: (2016) -
Predictive value of microvascular density for response to anlotinib in advanced NSCLC
por: Liu, Danqing, et al.
Publicado: (2022) -
Different histological types of triple metachronous primary lung carcinomas in 1 patient: Case report
por: Kim, Jee Hyuk, et al.
Publicado: (2017) -
Plasma levels of soluble programmed death ligand 1 (sPD-L1) in WHO II/III nasopharyngeal carcinoma (NPC): A preliminary study
por: Yang, Jia, et al.
Publicado: (2019)